NEWS

  • All
  • Press Release
  • Information

2018/08/29Press Release

We launched a collaborative research project for exploring new drug development for alzheimer’s disease with National Institutes for Quantum and Radiological Science and Technology.

View the press release (PDF)

2017/09/28Information

Our project "antiviral drug development for Human Papillomavirus(HPV), which causes cervical cancer", was adopted as a grant of the KYOTO Industrial Support Organization 21.

2017/08/24Information

Mr. Kuroishi, CEO,showed the status of our business regarding development of the anti-virus agentat the "IPO Caravan" sponsored by the Mitsubishi UFJ Trust Bank.

2017/08/04Information

Mr. Kuroishi, CEO, had an oral presentation at the "1st Healthcare Venture Conference KYOTO" held at the Kyoto Research Park.

2017/07/01Information

We established the Exploratory Research Laboratory at the Innovation Hub Kyoto of Kyoto University.

2017/03/03Information

NEDO Research Fund has been granted.

2018/08/29Press Release

We launched a collaborative research project for exploring new drug development for alzheimer’s disease with National Institutes for Quantum and Radiological Science and Technology.

View the press release (PDF)

2017/09/28Information

Our project "antiviral drug development for Human Papillomavirus(HPV), which causes cervical cancer", was adopted as a grant of the KYOTO Industrial Support Organization 21.

2017/08/24Information

Mr. Kuroishi, CEO,showed the status of our business regarding development of the anti-virus agentat the "IPO Caravan" sponsored by the Mitsubishi UFJ Trust Bank.

2017/08/04Information

Mr. Kuroishi, CEO, had an oral presentation at the "1st Healthcare Venture Conference KYOTO" held at the Kyoto Research Park.

2017/07/01Information

We established the Exploratory Research Laboratory at the Innovation Hub Kyoto of Kyoto University.

2017/03/03Information

NEDO Research Fund has been granted.